Search clinical trials for: Staphylococcus Aureus Bacteremia

Total 940 results

University of British Columbia

Completed

Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus

Staphylococcal Infections

Canada
University Hospital Tuebingen

Terminated

Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion

Pneumonia | Bacteremia

Germany
St. Justine's Hospital

Completed

Impact of Procalcitonin on the Management of Children Aged 1 to 36 Month Presenting With a Fever Without a Source

Bacteremia | Bacterial Infection | Procalcitonin | Fever Without Source

Canada
Rigshospitalet, Denmark

Completed

Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls

Healthy | Type 2 Diabetes | Endotoxemia

Denmark
Protalex, Inc.

Completed

Phase 1 Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of PRTX-100 in Healthy Adult Volunteers

Healthy Volunteers

United States
Radboud University Medical Center

Completed

Effect of Selective iNOS Inhibition During Human Endotoxemia

Endotoxemia

Netherlands
Radboud University Medical Center

Completed

Pathophysiology and Clinical Relevance of Endotoxin Tolerance in Humans

Endotoxemia

Netherlands
Hamilton Health Sciences Corporation

Unknown

UGIST: Ultrasound Guided Internal Jugular Short-Term Central Venous Catheters Tunneling (UGIST)

Bacteremia | Infection

Canada
Hillel Yaffe Medical Center

Unknown

Preoperative Nasal Swabs From Pediatric Patients

Staphylococcal Infections

Israel
Biosynexus Incorporated
GlaxoSmithKline

Completed

Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110 (N003)

Staphylococcal Sepsis

United States
Biosynexus Incorporated
GlaxoSmithKline

Completed

Safety and Pharmacokinetics Study in VLBW Neonates With BSYX-A110 (N002)

Neonatal Staphylococcal Sepsis

United States
Javeriana University
Asociacion Colombiana de Infectologia, ACIN. Infectious Diseases Society... and other collaborators

Completed

Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen (CEFPK/PD)

Sepsis | Bacteremia

Colombia
University of Pittsburgh
Elan Pharmaceuticals

Completed

Pharmacodynamic Parameters of Two Different Doses of Cefepime

Pneumonia | Bacteremia | Infection

United States
Beth Israel Medical Center

Terminated

The Role of Synbiotics in Reducing Post-Operative Infections in Patients Undergoing Cardiac Surgery: A Pilot Study

Pneumonia | Cystitis | Bacteremia | Surgical Wound Infection | Enterocolitis, Pseudomembranous

United States
Bristol-Myers Squibb

Completed

A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition

HIV Infections | Anorexia | Cachexia

United States
University Hospital Freiburg
University Hospital, Basel, Switzerland

Completed

Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride

Bacterial Infections | Bacteremia | Catheter-Associated Infections | Catheterization, Central Venous

Germany, Switzerland
Hunter Holmes Mcguire Veteran Affairs Medical Center
Centers for Disease Control and Prevention; Sage Products, Inc.

Unknown

Multicenter Trial of Daily Chlorhexidine Bathing to Reduce Nosocomial Infections (CBET)

MRSA Infection | MRSA Colonization | VRE Infection | VRE Colonization | Nosocomial Bacteremia

United States
Herzog Hospital

Terminated

Prevention of Bacteremia Induced by Debridement of Pressure Ulcer

Bacteremia | Pressure Ulcers

Israel
Medical University of Vienna

Completed

Anti-Inflammatory Effect of Statins in the Human Endotoxin Model

Endotoxemia

Austria
Rigshospitalet, Denmark
Royal Veterinary and Agricultural University, Denmark

Unknown

Type 2 Diabetes and the Effect of Probiotics

Healthy | Type 2 Diabetes | Endotoxemia

Denmark
Rigshospitalet, Denmark

Unknown

Study of Renal Blood Flow During Human Endotoxemia

Healthy | Type 2 Diabetes | Endotoxemia

Denmark
Hopital Lariboisière
Ministry of Health, France

Completed

Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis

Sepsis | Gram-Negative Bacterial Infections | Gram-Positive Bacterial Infections | Shock, Septic | Bacteremia | Pneumonia, Bacterial

France
University of Siena
Merck Sharp & Dohme LLC

Unknown

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

Skin Diseases | Pneumonia | Bacteremia | Urinary Tract Infections | Enterobacteriaceae Infections

Italy
NeuTec Pharma

Completed

Aurograb and Vancomycin in MRSA Infection

Staphylococcal Infections

United Kingdom
Medical University of Vienna

Completed

Ethnic Differences in the Inflammatory Response in Systemic Inflammation

Endotoxemia

Austria
Memorial Sloan Kettering Cancer Center

Completed

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Hematologic Malignancies | Streptococcal Sepsis

United States
National Taiwan University Hospital

Unknown

A Trial to Evaluate the Loading Dose Required to Achieve Therapeutic Serum Teicoplanin Concentration Timely

Staphylococcal Infections

Taiwan
Sheba Medical Center

Unknown

Clinical Outcome of Neonates With GBS Positive Culture-12 Year Retrospective Study

Infants With Positive GBS Bacteremia
National Taiwan University Hospital

Unknown

Procalcitonin in Diagnosing Bacteremia in the Emergency Department

Sepsis | Fever

Taiwan
Henry Ford Health System

Completed

Antibiotic Lock Solutions in the Prevention of Catheter Related Bacteremia

ESRD

United States
Herlev Hospital

Unknown

Low-Dose Endotoxemia and the Acute Phase Response

Sepsis | Endotoxemia

Denmark
BioWest Therapeutics Inc

Completed

Safety and Efficacy of MBI 226 for the Prevention of Central Venous Catheter-Related Bloodstream Infections

Sepsis | Fungemia | Bacteremia

United States
Vicuron Pharmaceuticals

Unknown

Safety and Efficacy of Dalbavancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections

Bacteremia

United States
Pharmacia

Completed

A Double-Blind Randomized Clinical Trial of a Rifabutin Regimen in the Treatment of Mycobacterium-Avium Complex (MAC) Bacteremia in Patients With AIDS

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Pharmacia

Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Pharmacia

Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in HIV Positive Patients With CD4 Counts = or < 200: Treatment IND Study

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
Pharmacia

Completed

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Anderson Clinical Research
Hoechst Marion Roussel

Completed

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States
Pharmacia

Completed

Rifabutin Therapy for the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in AIDS Patients With CD4 Counts = or < 200: A Double-Blind, Placebo-Controlled Trial

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States, Canada
Pharmacia

Completed

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

HIV Infections | Mycobacterium Avium-Intracellulare Infection

United States

Search clinical trials for: Staphylococcus Aureus Bacteremia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Liberia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations